Samuel Hall

Executive in Residence at Columbia Technology Ventures

Samuel Hall

Samuel Hall

Executive in Residence at Columbia Technology Ventures

Overview
RelSci Relationships

645

Number of Boards

4

Birthday

1982

Age

38

Contact Data
Trying to get in touch with Samuel Hall? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Samuel Hall likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Apple Tree Partners

Relationship likelihood: Strong

Partner at Apple Tree Partners

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Comet Therapeutics

Relationship likelihood: Strong

Co-Founder at Syntimmune, Inc.

Relationship likelihood: Strong

Scientific Founder at Syntimmune, Inc.

Relationship likelihood: Strong

Co-Founder at Verve Therapeutics, Inc.

Relationship likelihood: Strong

Chief Scientific Officer at Elstar Therapeutics, Inc.

Relationship likelihood: Strong

Deputy Director at Cold Spring Harbor Laboratory

Relationship likelihood: Strong

Chief Scientific Officer & Venture Partner at Apple Tree Partners

Relationship likelihood: Strong

Chief Executive Officer & Director at Stoke Therapeutics, Inc.

Relationship likelihood: Strong

Paths to Samuel Hall
Potential Connections via
Relationship Science
You
Samuel Hall
Executive in Residence at Columbia Technology Ventures
Education
Career History
Executive in Residence
Current

Columbia Technology Ventures (CTV) seeks to facilitate the commercialization of Columbia University's academic research into practical applications. CTV has extensive experience founding and supporting technology initiatives to enable promising technologies to accelerate and reach the market as quickly and successfully as possible.

Researcher
? - 2012

The University of Cambridge (informally known as Cambridge University or Cambridge) is a public research university located in Cambridge, United Kingdom. It is the second-oldest university in the English-speaking world (after the University of Oxford), and the seventh-oldest in the world.

Associate
Tenure Unconfirmed

Symphony Capital partners with innovative biopharmaceutical companies, helping them capture more of the value in their most important clinical development programs. Companies should have significant internally developed clinical programs or attractive in-licensed or acquired products. Each collaboration is a separate portfolio company in which the capitalization, clinical development design and management resources are customized to increase the development of 2-4 pipeline candidates of a single biopharmaceutical company.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Samuel Hall. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Samuel Hall's profile does not indicate a business or promotional relationship of any kind between RelSci and Samuel Hall.